Canalicular multispecific organic anion transporter 1

Target ID: CHEMBL5748

Organism: Homo sapiens

Type: SINGLE PROTEIN

View on ChEMBL

Molecules

Name SMILES Bioactivity Structure
METHOTREXATE CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1 ID50: 6.2 nM
IMATINIB MESYLATE CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1 EC50: 90.0 nM
GENISTEIN O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12 IC50: 1000.0 nM
FUROSEMIDE NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl Ki: 100000.0 nM
PAPAVERINE COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC Blood pressure: -23.0 mmHg
INAMRINONE Nc1cc(-c2ccncc2)c[nH]c1=O Mean ED50: 0.389 mg kg-1
AMINOPHYLLINE Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN IC50: 16700.0 nM
ERGOCALCIFEROL C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12 EC50: 3800.0 nM
ETHACRYNIC ACID C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl mequiv of Na+/kg: 4.14 0-5h
MIFEPRISTONE CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C IC50: 0.028 nM
ERLOTINIB C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1 IC50: 1450.0 nM
AMPRENAVIR CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1 Ki: 0.16 nM
AMITRIPTYLINE CN(C)CCC=C1c2ccccc2CCc2ccccc21 IC50: 61.0 nM
GATIFLOXACIN COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12 MIC: 0.05 ug.mL-1
ACETAZOLAMIDE CC(=O)Nc1nnc(S(N)(=O)=O)s1 Ki: 250.0 nM
ATENOLOL CC(C)NCC(O)COc1ccc(CC(N)=O)cc1 Pc: 1000000.0 cm s-1
EMETINE CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21 IC50: 40.0 nM
FLUCONAZOLE OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F IC80: 2.8 ug ml-1
AMIKACIN NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O C50: 0.21 uM
DIETHYLSTILBESTROL CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 EC50: 9.0 nM
ACETAMINOPHEN CC(=O)Nc1ccc(O)cc1 Vdss: 0.95 L.kg-1
GLYCYRRHIZIN CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@@](C)(C(=O)O)CC[C@]5(C)CC[C@@]4(C)[C@]3(C)CC[C@@H]12 Protection: 15.0 %
AMOXICILLIN CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O MIC: 0.021 ug.mL-1
ASTEMIZOLE COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1 Binding energy: 11.3 kCal mol-1
ATROPINE CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2 Ki: 0.45 nM
CAFFEINE Cn1c(=O)c2c(ncn2C)n(C)c1=O Vdss: 0.61 L.kg-1
QUERCETIN O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12 IC50: 32870.0 nM
AMILORIDE N=C(N)NC(=O)c1nc(Cl)c(N)nc1N Pc: 780000.0 cm s-1
SILDENAFIL CITRATE CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O IC50: 2.2 nM
LEVODOPA N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O IC50: 900000.0 nM
MIGLITOL OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO Inhibition: 50.0 %
FULVESTRANT C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O IC50: 0.49 nM
TOFACITINIB C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12 IC50: 13.0 nM
HYDROCHLOROTHIAZIDE NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O IC50: 181970085860998.25 nM
TRIMETHOPRIM COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC IC50: 12000.0 nM
PAZOPANIB Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O IC50: 10.0 nM
ESTRADIOL C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O IC50: 1.5 nM
IMATINIB Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1 IC50: 40.0 nM
BRINZOLAMIDE CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21 Ki: 37.0 nM
GEFITINIB COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1 IC50: 515.0 nM
TAMOXIFEN CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1 IC50: 6750.0 nM
BORTEZOMIB CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O Ki: 0.62 nM
DIPYRIDAMOLE OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1 IC50: 500.0 nM

Top Fragments

SMILES Avg pKi Count Structure
[5*]N[5*] 7.24 405
[3*]OC 6.2 229
[3*]O[3*] 7.03 225
[16*]c1ccc([16*])cc1 7.7 198
[1*]C([6*])=O 7.96 194